IMPLICATIONS OF GLOBAL ECONOMIC CRISIS ON BIOTECHNOLOGY INDUSTRY

Tatjana Papic-Brankov and Koviljko Lovre

Economics of Agriculture, 2010, vol. 57, issue 3

Abstract: In 2008, like the rest of the global economy, the biotech industry was faced with a world economic crisis and its consequences: dramatic reduction in available capital, the share price fall and reduction of the venture capital, and the closure of a significant number of companies. Despite the difficulties the financial results were more than favorable. The industry last year for the first time in the history of business has achieved overall profitability. Monsanto, the most important agricultural biotechnology company achieved record net profits from the sale. The paper concludes that the financial crisis contributed to the concentration of capital and strengthening the monopoly position of multinational companies.

Keywords: Environmental Economics and Policy; International Relations/Trade; Research and Development/Tech Change/Emerging Technologies (search for similar items in EconPapers)
Date: 2010
References: Add references at CitEc
Citations:

Downloads: (external link)
https://ageconsearch.umn.edu/record/245141/files/Article%202.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ags:iepeoa:245141

DOI: 10.22004/ag.econ.245141

Access Statistics for this article

More articles in Economics of Agriculture from Institute of Agricultural Economics Contact information at EDIRC.
Bibliographic data for series maintained by AgEcon Search ().